Sign In
Buy NEO
$10.14
+0.0200 (+0.198%)
At Close: Jun 03, 2026
NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter
07:00am, Wednesday, 05'th May 2021
First-Quarter 2021 Results and Highlights: Consolidated revenue increased 9% to $116 million Clinical Services revenue increased 4% to $96 million Pharma Services revenue increased 46% to $19 million
NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
12:00am, Wednesday, 05'th May 2021
Establishes NeoGenomics as a technology leader in the minimal residual disease (MRD) testing market NeoGenomics exercises option struck in May 2020 to purchase remaining equity stake for $390 million
SGT Program will provide KRAS G12C testing to eligible patients at no cost, regardless of insurance type. FT. MYERS, FL / ACCESSWIRE / April 19, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provid
NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference
07:00am, Tuesday, 13'th Apr 2021
FT. MYERS, FL / ACCESSWIRE / April 13, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today ann
NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021
04:05pm, Wednesday, 07'th Apr 2021
FT MYERS, FL / ACCESSWIRE / April 7, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to
Strength Seen in NeoGenomics (NEO): Can Its 7.9% Jump Turn into More Strength?
06:49am, Thursday, 01'st Apr 2021
NeoGenomics (NEO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NeoGenomics Agrees to Acquire Trapelo Health
07:00am, Wednesday, 24'th Mar 2021
Clinical Decision Support to Enable Precision Oncology FT. MYERS, FL / ACCESSWIRE / March 24, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and
NEW YORK and FORT MYERS, Fla., March 16, 2021 /PRNewswire/ -- Elevation Oncology , a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with geno
NeoGenomics (NEO) CEO Doug VanOort on Q4 2020 Results - Earnings Call Transcript
02:32pm, Wednesday, 24'th Feb 2021
NeoGenomics (NEO) CEO Doug VanOort on Q4 2020 Results - Earnings Call Transcript
Recap: NeoGenomics Q4 Earnings
07:49am, Wednesday, 24'th Feb 2021
Shares of NeoGenomics (NASDAQ:NEO) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share rose 40.00% over the past year to $0.14, which beat the estimate of $0.06.
3 Fast Growing Revenue Stock Picks
11:25am, Friday, 05'th Feb 2021
The S&P 500 Index stocks saw their aggregate trailing 12-month revenue per share increase at a compound average growth rate (CAGR) of 2% per annum over the past five years. The share price of the inde
NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
04:05pm, Tuesday, 05'th Jan 2021
FORT MYERS, FL / ACCESSWIRE / January 5, 2021 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading provider of cancer-focused genetics testing services and global oncology contract research ser
NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference
07:30am, Monday, 04'th Jan 2021
FT. MYERS, FL / ACCESSWIRE / January 4, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today annou
NeoGenomics: ~27% Upside Potential Is Under-Reflected, Market Is Unfairly Discounting Shares
11:11am, Tuesday, 22'nd Dec 2020
NeoGenomics remains insulated and differentiated from peers via a plethora of offerings in clinical diagnostics, as a potential market-leader in oncology services. The growth vision looks at consolida
Top 10 Healthcare Stocks for the Future
06:44am, Sunday, 29'th Nov 2020
In this article we present the list of Top 10 Healthcare Stocks for the Future. Click to skip ahead and see the Top 5 Healthcare Stocks for the Future .
